- Trials with a EudraCT protocol (172)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
172 result(s) found for: Inflammatory Cytokine.
Displaying page 1 of 9.
EudraCT Number: 2018-002173-22 | Sponsor Protocol Number: 201800406 | Start Date*: 2018-12-04 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Anti-inflammatory effects of tiotropium in patients with stable COPD | ||
Medical condition: Chronic obstructive pulmonary disease (COPD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000656-35 | Sponsor Protocol Number: 73042 | Start Date*: 2020-09-09 |
Sponsor Name:Radboud University Medical Centre | ||
Full Title: The inflammatory response of monocytes and neutrophils to Crystals after Low dose colchicine in patients with coronary artery disease | ||
Medical condition: Atherosclerosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002753-11 | Sponsor Protocol Number: TofaSTAT17 | Start Date*: 2018-01-25 |
Sponsor Name:Tampere University Hospital | ||
Full Title: The effect of tofacitinib on the activity of JAK-STAT pathways in patients with rheumatoid arthritis (RA) | ||
Medical condition: Rheumatoid arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003854-80 | Sponsor Protocol Number: 02B2005 | Start Date*: 2006-01-31 |
Sponsor Name:Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University | ||
Full Title: Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral versus Central | ||
Medical condition: Patients with osteoarthritis undergoing elective primary single hip arthroplasty | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002222-70 | Sponsor Protocol Number: Lidobreast | Start Date*: 2013-11-15 |
Sponsor Name:University Medical Centre St Radboud | ||
Full Title: Pilot study: Targeting the inflammatory response after breast cancer surgery with lidocaïne and dexamethasone | ||
Medical condition: Breast cancer patients who undergo surgery for treatment. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001971-61 | Sponsor Protocol Number: SALYCENDO | Start Date*: 2016-08-29 |
Sponsor Name:Radboudumc | ||
Full Title: The effects of acetylsalicylic acid on immunoparalysis following human endotoxemia. | ||
Medical condition: We will investigate the effects of acetylsalicylic acid on immunoparalysis following human endotoxemia in healthy male volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005537-30 | Sponsor Protocol Number: NL_ABR51923 | Start Date*: 2015-06-09 |
Sponsor Name:Radboud university medical center | ||
Full Title: Does ticagrelor modulate the inflammatory respons to human endotoxemia? | ||
Medical condition: We will study in male healthy volunteers whether ticagrelor modulates the inflammatory response to the administration of lipopolysaccharide (LPS) in humans in vivo. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003018-29 | Sponsor Protocol Number: 2016-003018-29 | Start Date*: 2017-05-31 |
Sponsor Name:Herlev and Gentofte Hospital | ||
Full Title: Apremilast as anti-pruritic treatment in patients with prurigo nodularis | ||
Medical condition: Prurigo nodularis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-004078-53 | Sponsor Protocol Number: 83403 | Start Date*: 2023-08-22 |
Sponsor Name:Academic Medical Center (AMC), department of Internal Medicine | ||
Full Title: Specifying the anti-inflammatory effects of ziltivekimab with diverse imaging modalities and in-depth cellular phenotyping | ||
Medical condition: - Plaque characteristics - Systemic inflammation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000924-14 | Sponsor Protocol Number: S52549 | Start Date*: 2011-05-23 |
Sponsor Name:KU Leuven LRD | ||
Full Title: Development and validation of a sputum biomarker mRNA panel for the diagnostic work-up of asthma | ||
Medical condition: asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002273-41 | Sponsor Protocol Number: OPHT-110106 | Start Date*: 2006-06-12 |
Sponsor Name:Medical University of Vienna; Clinical Pharmacology | ||
Full Title: Effect of antioxidants on ocular blood flow, endothelial function, and cytokine levels in LPS induced inflammatory model in humans. | ||
Medical condition: only healthy volunteers are involved | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004974-16 | Sponsor Protocol Number: IL1ra03 | Start Date*: 2018-11-08 | ||||||||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge | ||||||||||||||||||
Full Title: DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMISED CLINICAL DOSE-RANGING STUDY TREATING MODERATE-SEVERE TRAUMATIC BRAIN INJURY PATIENTS WITH RECOMBINANT HUMAN INTERLEUKIN 1 RECEPTOR ANTAGONIST. | ||||||||||||||||||
Medical condition: We wish to study the drug Kineret in patients suffering from moderate-to-severe traumatic brain injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-006263-23 | Sponsor Protocol Number: ML20910 | Start Date*: 2006-12-05 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: Efficacy of Oseltamivir treatment in laboratory- confirmed influenza: evaluation of effect on viral shedding and on serum and cytoplasmatic inflammatory cytokine concentration. | |||||||||||||
Medical condition: Influenza type A and B virus infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004938-42 | Sponsor Protocol Number: EHRVI | Start Date*: 2013-03-01 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: Experimental Human Rhinovirus Infection, a randomized placebo-controlled pilot study | |||||||||||||
Medical condition: Viral infections in general, and the "common cold" induced by HRV-16 in particular. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003325-22 | Sponsor Protocol Number: 2022-15944 | Start Date*: 2023-01-25 |
Sponsor Name:RadboudUMC | ||
Full Title: The immunomodulatory effect of sugammadex after total hip replacement surgery under neuraxial anaesthesia: a pilot study | ||
Medical condition: Hip osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005227-37 | Sponsor Protocol Number: OLT1177-10 | Start Date*: 2021-03-03 | |||||||||||
Sponsor Name:Olatec Therapeutics LLC | |||||||||||||
Full Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Orally Administered Dapansutrile Capsules for the Treatment of Moderate COVID-19 Symptoms and Evidence of ... | |||||||||||||
Medical condition: COVID-19, cytokine release syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002860-86 | Sponsor Protocol Number: 2007/099 | Start Date*: 2007-06-26 |
Sponsor Name:Radboud University Nijmegen Medical Centre | ||
Full Title: The adenosine receptor; a new pharmacological tool in the treatment of sepsis. | ||
Medical condition: Systemic inflammatory response | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002978-52 | Sponsor Protocol Number: CNTO1959HDS2002 | Start Date*: 2019-07-16 |
Sponsor Name:Universitair Medisch Centrum Groningen | ||
Full Title: Guselkumab for hidradenitis suppurativa, a mode of action study. | ||
Medical condition: Hidradenitis suppurativa | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003755-39 | Sponsor Protocol Number: CRx-102-001 | Start Date*: 2004-09-29 |
Sponsor Name:CombinatoRx, Inc | ||
Full Title: A SINGLE CENTER, SINGLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY OF THE EFFECT OF CRx-102 COMPARED TO PLACEBO ON SERUM C-REACTIVE PROTEIN (CRP) AND INFLAMMATORY CYTOKINES IN SUBJECTS WITH SEVERE... | ||
Medical condition: Severe adult periodontitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000435-13 | Sponsor Protocol Number: JWGKDVAAP0117 | Start Date*: 2017-11-13 |
Sponsor Name:University Hospital Frankfurt for its Dermatology Department, Clinical Research | ||
Full Title: Exploratory study to evaluate changes in inflammatory pattern and analysis for serum biomarkers in patients with active, moderate-to-severe hidradenitis suppurativa after 2-week and 6-week treatmen... | ||
Medical condition: Hidradenitis suppurativa is defined as a chronic inflammatory disease of the intertriginous area, including the axilla, groin and anogenital or submammary regions. The condition is characterized by... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.